期刊文献+

克拉拉细胞分泌蛋白16在儿童肺部疾病诊治中的研究进展

Progress in diagnosis and treatment of CC16 in children pulmonary disease
原文传递
导出
摘要 克拉拉细胞分泌蛋白16(Clara cell secretory protein 16,CC16)是呼吸道上皮Clara细胞最主要的分泌蛋白之一,主要存在于肺上皮细胞衬液中,当支气管肺泡-毛细血管膜屏障受损时CC16会大量进入血液,最终随着尿液排出体外。近年来,越来越多研究发现CC16不仅具有抗炎、调节免疫、抗氧化和抗纤维化等作用,其浓度水平的变化还是反应气道上皮完整性的一个敏感指标,能预测多种儿童肺部疾病的发生发展。该文主要对CC16的生物学特性及作用进行总结,并就其在儿童肺部疾病诊治中的研究进展作一综述。 Clara cell secretory protein 16(CC16)is one of the most important secreted proteins of Clara cells in respiratory epithelium,which mainly exists in the lining fluid of lung epithelial cells.When the bronchoalveolus-capillary membrane barrier is damaged,a large amount of CC16 will enter the blood.It′s eventually excreted in the urine.In recent years,more and more studies have found that CC16 not only has anti-inflammatory,immune-modulating,anti-oxidation and anti-fibrosis effects,but also is a sensitive indicator of the integrity of the airway epithelium,which can predict the occurrence and development of many children′s pulmonary diseases.This article mainly summarizes the biological characteristics and functions of CC16,and summarizes the research progress of CC16 in the diagnosis and treatment of pediatric pulmonary diseases.
作者 黎历(综述) 晋兴楠 王旭 邹映雪(审校) Li Li;Jin Xingnan;Wang Xu;Zou Yingxue(Respiratory Department of Machang District,Tianjin Children′s Hospital(Tianjin University Children′s Hospital),Tianjin 300074,China)
出处 《国际儿科学杂志》 2022年第9期625-628,共4页 International Journal of Pediatrics
基金 天津市自然基金重大项目(20JCZDJC00630)。
关键词 儿童 克拉拉细胞分泌蛋白16 CLARA细胞 肺部疾病 Children Clara cell secretory protein 16 Clara cell Pulmonary disease
  • 相关文献

参考文献2

二级参考文献40

  • 1陈幽,吴志军,韩玉昆,卢光进.早产儿机械通气治疗后支气管肺发育不良危险因素分析[J].中国小儿急救医学,2006,13(5):426-428. 被引量:4
  • 2翟亮,于凤英,吴红敏.肺表面活性蛋白的基因多态性与呼吸窘迫综合征[J].国际儿科学杂志,2007,34(5):340-343. 被引量:3
  • 3Jobe AH. The new bronchopulmonary dysplasia[ J]. Curt Opin Pedi- atr,2011,23 (2) :167-172.
  • 4Ruegger C, Hegglin M, Adams M, et al. Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years [ J ]. BMC Pediatr,2012,12 : 17.
  • 5Perez PG, Navarro MM. Bronchopulmonary dysplasia and prematuri- ty. Short-and long-term respiratory changes[ J]. An Pediatr (Barc), 2010,72( 1 ) :71-79.
  • 6Lavoie PM, Dube MP. Genetics of bronchopulmonary dysplasia in the age of genomics[ J]. Curt Opin Pediatr,2010,22 (2) : 134-138.
  • 7Somaschini M, Castiglioni E, Volonteri C, et al. Genetic predisposing factors to bronchopulmonary dysplasia:preliminary data from a multi- centre study[ J]. J Matem Fetal Neonatal Med,2012,25 ( Suppl 4 ) : 127-130.
  • 8Floros J,Londono D,Gordon D,et al. IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-A- merican infants[ J]. Pediatr Res,2012,71 ( 1 ) : 107-114.
  • 9Pastva AM, Walker JK, Maddox LA, et al. Nitric oxide mediates rela- tive airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice [ J ]. Am J Respir Cell Mol Biol, 2011,44 (2) :175-184.
  • 10Hayes D J, Feola D J, Murphy BS, et al. Pathogenesis of bronchopult monary dysplasia[ J ]. Respiration, 2010,79 ( 5 ) : 425 -436.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部